Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Life (Basel, Switzerland)|June 24, 2022
Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New TherapiesKonstantinos Rounis, Dimitrios Makrakis, Ioannis Gioulbasanis, et al.
Acta Oncologica (Stockholm, Sweden)|January 9, 2020
Treatment patterns and survival outcomes for small-cell lung cancer patients - a Swedish single center cohort studySalomon Tendler, Yiqiang Zhan, Andreas Pettersson, et al.
Proteome Science|March 2, 2010
A novel method for sample preparation of fresh lung cancer tissue for proteomics analysis by tumor cell enrichment and removal of blood contaminantsLuigi De Petris, Maria Pernemalm, Göran Elmberger, et al.
Cancers|April 3, 2021
Correlation of Clinical Parameters with Intracranial Outcome in Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Pd-1/Pd-L1 Inhibitors as MonotherapyKonstantinos Rounis, Marcus Skribek, Dimitrios Makrakis, et al.
Lung Cancer (Amsterdam, Netherlands)|July 16, 2008
Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancerLuigi De Petris, Lukas M Orre, Lena Kanter, et al.
Proteomics|July 18, 2009
Use of narrow-range peptide IEF to improve detection of lung adenocarcinoma markers in plasma and pleural effusionMaria Pernemalm, Luigi De Petris, Hanna Eriksson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 9, 2021
Effect of corticosteroids on the outcome of patients with advanced non-small cell lung cancer treated with immune-checkpoint inhibitorsMarcus Skribek, Konstantinos Rounis, Soren Afshar, et al.
Histology and Histopathology|March 11, 2025
NTRK protein expression in NSCLC and its clinicopathological correlationJair Gutierrez-Herrera, M Angeles Montero-Fernandez, Luigi De Petris, et al.
Cancers|December 16, 2020
Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a 'Real-Life' SettingMarcus Skribek, Konstantinos Rounis, Dimitrios Makrakis, et al.
Acta Oncologica (Stockholm, Sweden)|October 7, 2017
Prognostic factors affecting survival after whole brain radiotherapy in patients with brain metastasized lung cancerGeorgios Tsakonas, Fatou Hellman, Michael Gubanski, et al.
Pageof 7